BeiGene, Ltd. is 10% Owner at LEAP THERAPEUTICS, INC. (LPTX). They have made 1 open-market trade across 1 company since 2021, most recently 2021-09-24.
CIK 0001651308
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $7.2M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LPTX | 7,348,437 | $15.1M |
Shares reported on the most recent Form 4, priced at the 2021-09-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LPTX | BUY | 2021-09-24 | 2021-09-28 | $2.85 | $7.2M | -7.9% | -22.7% | -21.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.